This site is intended for health professionals only

Editor’s pick

Two New Board Directors Appointed
Two New Board Directors Appointed
Cimzia shows sustained clinical improvements
Cimzia shows sustained clinical improvements
Updated results for Revlimid
Updated results for Revlimid
Lower costs are key to the competitive advantage of DCVax
Lower costs are key to the competitive advantage of DCVax
RA drug safety trial successful
RA drug safety trial successful
FDA to publish drug safety reviews
FDA to publish drug safety reviews
New data from EMBLEM study
New data from EMBLEM study
Flexible thinking can help build for the future
Flexible thinking can help build for the future
Ocean may hold key to new medicines
Ocean may hold key to new medicines
Elderly patients missing out on optimal treatment of haematological disorders
Elderly patients missing out on optimal treatment of haematological disorders
Senexis sign agreement with O2h
Senexis sign agreement with O2h
Study links cancer to use of ARBs
Study links cancer to use of ARBs
1 … 60 61 62 63 64 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x